Open Access. Powered by Scholars. Published by Universities.®
Cell and Developmental Biology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Cell rehab (1)
- Cellular therapy (1)
- Embryonic stem cells (1)
- HeLa Cells (1)
- Immunoblot (1)
-
- Immunofluorescence (1)
- Induced pluripotent stem cells (1)
- Nucleoporins (1)
- Nucleus (1)
- Personalized medicine (1)
- Regenerative cell therapy (1)
- Regenerative cells (1)
- Regenerative healthcare (1)
- Regenerative medicine (1)
- Regenerative rehabilitation (1)
- Regenerative therapy (1)
- Stem cell (1)
- Stem cell rehabilitation (1)
- Stem cell therapy (1)
- Stem cells (1)
- Stem cells impact (1)
Articles 1 - 2 of 2
Full-Text Articles in Cell and Developmental Biology
Effect Of Her2 Expression On Nupl2 Protein In Cervical Cancer Cells, Mary E. Eichholz, Margaret J. Ballou, Tristan J. Haight, Jennifer L. Minton, Ryan N. Oates, Jacob J. Adler
Effect Of Her2 Expression On Nupl2 Protein In Cervical Cancer Cells, Mary E. Eichholz, Margaret J. Ballou, Tristan J. Haight, Jennifer L. Minton, Ryan N. Oates, Jacob J. Adler
Kentucky Journal of Undergraduate Scholarship
Recurring cervical cancer patients frequently present overexpressed Human Epidermal Growth Factor Receptor 2 (HER2) protein, which promotes the growth of the cancer. Some HER2-expressing cells and cervical cancer patients have enhanced gene expression of Nucleoporin-like 2 (NUPL2). As part of the nuclear pore complex, the NUPL2 protein serves to selectively export substances from the nucleus to the cytoplasm. In this experiment, HER2 was expressed in cervical cancer cells to examine its effect on NUPL2 protein expression and localization. Interestingly, there was no difference in NUPL2 protein levels between HER2-expressing and non-expressing cells. Importantly, consistent instances of NUPL2 protein …
Understanding Regenerative Medicine And Its Position In Healthcare, Tyler F. Ward
Understanding Regenerative Medicine And Its Position In Healthcare, Tyler F. Ward
Kentucky Journal of Undergraduate Scholarship
Abstract: Regenerative medicine is an emerging field of the healthcare industry that has the potential to treat a myriad of health conditions. Induced pluripotent stem cells, human embryonic stem cells, and tissue engineering are a few of the treatment methods that may be delivered by healthcare professionals in personalized medicine. Food and Drug Administration (FDA) approval is necessary within the United States before any of these treatment options are available. Specific cellular therapies are currently undergoing clinical trials and it may be years before approval is acquired. The National Institute of Health is proactively working to ensure that healthcare policies, …